TrialCancer research and treatment2019

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study.

So-Yeon Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.